Reactivity of T cells from seronegative patients with myasthenia gravis to T cell epitopes of the human acetylcholine receptor

Neurology

Volumn 48, Issue 6, 1997, Pages 1638-1642

  Karni, Arnon ^a   Zisman, E ^b   Katz Levy, Y ^b   Paas Rozner, M ^b   Dayan, M ^b   Brautbar, C ^a   Abramsky, O ^a   Sela, M ^b   Mozes, E ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; EPITOPE; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PREDNISONE; SYNTHETIC PEPTIDE;

ADULT; AGED; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; MYASTHENIA GRAVIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SEROLOGY; T LYMPHOCYTE;

EID: 33744947575     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.6.1638     Document Type: Article

References (34)

1. Drachman DB. Myasthenia gravis. N Engl J Med 1994;330: 1797-1810.
2. Engel AG, Lambert EH, Howard FM. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis. Mayo Clin Proc 1977;52:267-280.
3. Drachman DB, Adams RN, Josifek LF, Self SG. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N Engl J Med 1982;307: 769-775.
4. Toyka KV, Drachman DB, Griffin DE, et al. Myasthenia gravis: study of humoral immune mechanisms by passive transfer to mice. N Engl J Med 1977;296:125-131.
5. Dau PC, Lindstrom JM, Cassel CK, Denys EH, Shev EE, Spitler LE. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N Engl J Med 1977;297:1134-1140.
6. Vincent A, Xewsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry 1985;48:1246-1252.
7. Mossman S, Vincent A, Newsom-Davis J. Myasthenia gravis without acetylcholine receptor antibody: a distinct disease entity. Lancet 1986;1:116-119.
8. Soliven BC, Lange DJ, Penn AS, et al. Seronegative myasthenia gravis. Neurology 1988;38:514-517.
9. Birmanns B, Brenner T, Abramsky O, Steiner I. Seronegative myasthenia gravis: clinical features, response to therapy and synthesis of acetylcholine receptor antibodies in vitro. J Neurol Sci 1991;102:184-189.
10. 3H-I cells: positive results in 'antibody-negative' myasthenia gravis. J Neuroimmunol 1990;28:83-93.
11. Drachman DB, de Silva S, Ramsay D, Pestronk A. Humoral pathogenesis of myasthenia gravis. Ann NY Acad Sci 1987; 505:90-105.
12. Vincent A, Li Z, Hart A, et al. Seronegative myasthenia gravis: evidence for plasma factor(s) interfering with acetylcholine receptor function. Ann NY Acad Sci 1993;681:529-538.
13. Yamamoto T, Vincent A, Ciulla TA, Lang B, Johnston I, Newsom-Davis J. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM. Ann Neurol 1991;30:550-557.
14. Hohlfeld R, Toyka KV, Heininger K, Grosse-Wilde H, Kalies I. Autoimmune human T lymphocytes specific for acetylcholine receptor. Nature 1984;310:244-246.
15. Hohlfeld R, Kalies I, Kohleisen B, Heininger K, Conti-Tronconi B, Toyka KV. Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines. Neurology 1986;36:618-621.
16. Waldor MK, Sriram S, McDevitt HO, Steinman L. In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor. Proc Natl Acad Sci USA 1983;80:2713-2717.
17. Christadoss P, Dauphinee MJ. Immunotherapy for myasthenia gravis: a murine model. J Immunol 1986;136:2437-2440.
18. Hohlfeld R, Toyka KV, Tzartos SJ, Carson W, Conti-Tronconi BM. Human T helper lymphocytes in myasthenia gravis recognize the nicotinic receptor α-subunit. Proc Natl Acad Sci USA 1987;84:5379-5383.
19. Fujii Y, Lindstrom J. Regulation of antibody production by helper T-cell clones in experimental autoimmune myasthenia gravis. J Immunol 1988;141:3361-3369.
20. Zhang Y, Barkas T, Juillerat M, Schwendimann B, Wekerle H. T-cell epitopes in experimental autoimmune myasthenia gravis of the rat: stain-specific epitopes and cross-reaction between two distinct segments of the a chain of the nicotinic acetylcholine receptor (Torpedo californica). Eur J Immunol 1988;18:551-557.
21. Harcourt GC, Sommer N, Rothbard J, Willcox HNA, NewsomDavis J. A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis. J Clin Invest 1988;82:1295-1300.
22. Brocke S, Brautbar C, Steinman L, et al. In vitro proliferative responses and antibody liters specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes. J Clin Invest 1988;82: 1894-1900.
23. Moiola L, Protti MP, Manfredi AA, Yuen MH, Howard Jr JF, Conti-Tronconi BM. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis. Ann NY Acad Sci 1993;681:198-218.
24. McCormick DJ, Griemann GE, Huang ZX, Lambert EH, Lennon VA. Myasthenogenicity of human acetylcholine receptor synthetic α-subunit peptide 125-147 does not require intramolecular disulfide cyclization. J Immunol 1987;139:2615-2619.
25. Kirshner SL, Katz-Levy Y, Wirguin I, Argov Z, Mozes E. Fine specificity of T cell lines and clones that are capable of inducing autoimmune manifestations in mice. Cell Immunol 1994; 157:11-28.
26. Buus S, Sette A, Grey HM. The interaction between protein-derived immunogenic peptides and 1a. Immunol Rev 1987;98: 115-141.
27. Mozes E, Dayan M, Zisman E, Brocke S, Licht A, Pecht I. Direct binding of a myasthenia gravis related epitope to MHC class II molecules on living murine antigen-presenting cells. EMBO J 1989;8:4049-4052.
28. Zisman E, Mozes E. Processing requirements of two acetylcholine receptor derived peptides for binding to antigen-presenting cells and stimulation of murine T cell lines. Int Immunol 1994;6:683-691.
29. Zisman E, Brautbar C, Sela M, et al. Binding of peptides of the human acetylcholine receptor α-subunit to HLA class II of patients with myasthenia gravis. Hum Immunol 1995;44:121-130.
30. Zisman E, Katz-Levy Y, Dayan M, et al. Peptides analogs to pathogenic epitopes of the human acetylcholine receptor α-subunit as potential modulators of myasthenia gravis. Proc Natl Acad Sci USA 1996;93:4492-4497.
31. Katz D, Bentwich Z, Eshhar N, Löwy I, Mozes E. Immune response potential to poly (Tyr,Glu)-poly(DLAla) - poly(Lys) of human T cells of different donors. Proc Natl Acad Sci USA 1981;78:4505-4509.
32. Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y. Microdroplet testing for HLA-A, B, C and D antigens. Am J Clin Pathol 1978;69:103-120.
33. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells [abstract]. Nucleic Acid Res 1988;16:1215.
34. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop. Reference protocol for the HLA DNA typing technique. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991, vol 1, w3.3. New York: Oxford University Press, 1992:397-419.